NM_006267.5:c.8188A>C
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBS2_Supporting
The NM_006267.5(RANBP2):c.8188A>C(p.Lys2730Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000057 in 1,613,990 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K2730N) has been classified as Uncertain significance.
Frequency
Consequence
NM_006267.5 missense
Scores
Clinical Significance
Conservation
Publications
- familial acute necrotizing encephalopathyInheritance: AD Classification: STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- Leigh syndromeInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_006267.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RANBP2 | NM_006267.5 | MANE Select | c.8188A>C | p.Lys2730Gln | missense | Exon 23 of 29 | NP_006258.3 | ||
| RANBP2 | NM_001415871.1 | c.8266A>C | p.Lys2756Gln | missense | Exon 24 of 30 | NP_001402800.1 | |||
| RANBP2 | NM_001415873.1 | c.8188A>C | p.Lys2730Gln | missense | Exon 23 of 29 | NP_001402802.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RANBP2 | ENST00000283195.11 | TSL:1 MANE Select | c.8188A>C | p.Lys2730Gln | missense | Exon 23 of 29 | ENSP00000283195.6 | ||
| RANBP2 | ENST00000697745.1 | c.3052A>C | p.Lys1018Gln | missense | Exon 4 of 10 | ENSP00000513429.1 | |||
| RANBP2 | ENST00000697737.1 | c.2941A>C | p.Lys981Gln | missense | Exon 21 of 27 | ENSP00000513426.1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152206Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000478 AC: 12AN: 251278 AF XY: 0.0000295 show subpopulations
GnomAD4 exome AF: 0.0000588 AC: 86AN: 1461784Hom.: 0 Cov.: 31 AF XY: 0.0000619 AC XY: 45AN XY: 727188 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152206Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74346 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Familial acute necrotizing encephalopathy Uncertain:2
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C45". The glutamine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with RANBP2-related disease. ClinVar contains an entry for this variant (Variation ID: 431720). This variant is present in population databases (rs747890333, ExAC 0.02%). This sequence change replaces lysine with glutamine at codon 2730 of the RANBP2 protein (p.Lys2730Gln). The lysine residue is highly conserved and there is a small physicochemical difference between lysine and glutamine.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at